Skip to content

Evaluation of efficacy and safety of Excimer Laser Coronary Atherectomy for treatment of severely CALCified coronary stenoses Registry

Study of excimer laser coronary atherectomy for interventional treatment of severe calcified coronary stenoses

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300075823
Enrollment
Unknown
Registered
2023-09-15
Start date
2023-09-15
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Interventions

ELCA:NA

Sponsors

Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age>18 years old; 2. Diagnosed as stable angina, silent myocardial ischemia, unstable angina, non-ST-segment elevation myocardial infarction, or ST-segment elevation myocardial infarction (>7 days from onset); 3. De novo coronary lesion; 4. Coronary artery calcium score (calculated by the Agatston method) >200 derived from the non-contrast chest computerized tomography scanned before the index procedure; 5. Planned to receive invasive coronary angiography; 6. Reference vessel diameter as 2.5-4.0mm of target lesion by visual estimation; 7. Lesions requiring excimer laser coronary atherectomy according to the operator’s judgement during the procedure; 8. Written consent acquired from the participant or his/her authorized agent before entering the study; 9. Willingness to adhere with the whole study procedure

Exclusion criteria

Exclusion criteria: 1. Contraindications of excimer laser coronary atherectomy use according to the operator’s judgement

Design outcomes

Primary

MeasureTime frame
ELCA success;

Secondary

MeasureTime frame
Technical success;Procedure success;Stent underexpansion;Death;Myocardial infarction;Stroke;Target vessel revascularization;Stent thrombosis;Hospitalization due to cardiac causes;Bleeding;Severity of angina defined by CCS;Severity of angina evaluated by Seattle Angina Questionnaiire;

Countries

China

Contacts

Public ContactLinghong Shen

Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine

drshenlinghong@126.com+86 139 1649 5713

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026